SpineX Inc. develops non-invasive spinal cord neuromodulation devices, SCiP™ and SCONE™, to treat the root causes of cerebral palsy and urinary incontinence due to neurogenic bladder conditions. Their technology utilizes transcutaneous electrical stimulation to restore neurological function, significantly improving quality of life for affected individuals.
Funding
$4M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Cerebral palsy and neurogenic bladder conditions resulting from spinal cord injury, stroke, or multiple sclerosis can severely diminish quality of life. Current treatment options often fail to address the underlying neurological deficits causing these conditions.
Solution
SpineX is developing non-invasive spinal cord neuromodulation devices designed to treat the root causes of cerebral palsy and urinary incontinence due to neurogenic bladder. Their technology, utilizing transcutaneous electrical stimulation, aims to restore neurological function by delivering electrical charges to the spinal cord through electrodes placed on the skin. This stimulation activates intrinsic control of spinal networks, potentially enabling recovery of voluntary control and improving the lives of individuals affected by these conditions. The Spinal Cord Innovation in Pediatrics (SCiP™) device targets cerebral palsy, while the Spinal Cord Neuromodulator (SCONE™) device addresses urinary incontinence.
Target Audience
The primary target audience includes individuals with cerebral palsy and those experiencing urinary incontinence due to neurogenic bladder resulting from spinal cord injury, stroke, or multiple sclerosis, as well as the clinicians who treat these conditions.
Features
- Non-invasive transcutaneous electrical stimulation of the spinal cord
- SCiP™ device designed to treat the underlying neurological causes of cerebral palsy in pediatric patients
- SCONE™ device developed for urinary incontinence due to neurogenic bladder in adults with spinal cord injury, multiple sclerosis, or stroke
- External electrodes placed on the skin to deliver targeted electrical stimulation
- Technology aims to activate intrinsic control of spinal networks for functional recovery